Novo Nordisk ( NVO 0.22%) and Constellation Brands ( STZ -1.15%) are both dividend-paying members of the S&P 500 index. Their stock prices are down sharply over the past 12 months, but investment bank ...

Three stocks with yields that are less than 2% but that have been increasing their dividends at high rates in recent years ...

The rise of Ozempic and weight-loss drugs is a convenient excuse for the fashion industry and retailers to cut back on plus-size clothing options.

WeightWatchers has emerged from bankruptcy after slimming down its debts, as it pledged to combine weight-loss jabs with ...

Skye’s Nimacimab shows promise in obesity treatment with lean mass preservation. Phase 2a results slated for 2025 could drive ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

Walmart's valuation may be overhyped amidst industry headwinds and risks like SNAP cuts, tariffs, and shifting consumer ...

We spoke with Tahiri about the evolution of nutrition innovation, the importance of understanding consumers on a deeper level ...

California Trim Rx has been providing a local, community-based experience for residents in Encinitas and the surrounding ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?